🇺🇸 FDA
Patent

US 10849867

Methods and compositions for treating conditions associated with an abnormal inflammatory response

granted A61KA61K31/167A61K45/06

Quick answer

US patent 10849867 (Methods and compositions for treating conditions associated with an abnormal inflammatory response) held by First Wave Bio, Inc. expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
First Wave Bio, Inc.
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/167, A61K45/06, A61K47/32, A61K47/38